New York bills · 2025 Regular Session
New York A 2145
Relates to the labeling of mifepristone, misoprostol, and their generic alternatives
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Karines Reyes (Democratic)
Cosponsors (6)
- Anna Kelles (Democratic/Working Families)
- Jonathan Jacobson (Democratic)
- Nily Rozic (Democratic)
- Linda Rosenthal (Democratic)
- Grace Lee (Democratic)
- Charles Lavine (Democratic)
Summary
Official abstract published by the New York legislature
Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 22, 2025 · House
SUBSTITUTED BY S36A - Jan 22, 2025 · House
ORDERED TO THIRD READING RULES CAL.61 - Jan 22, 2025 · House
RULES REPORT CAL.61 - Jan 22, 2025 · House
REPORTED - Jan 22, 2025 · House
REPORTED REFERRED TO RULES - Jan 16, 2025 · House
PRINT NUMBER 2145A - Jan 16, 2025 · House
AMEND (T) AND RECOMMIT TO HIGHER EDUCATION - Jan 15, 2025 · House
REFERRED TO HIGHER EDUCATION